Nom du produit:3-benzyl-1-(cyclopropylmethyl)-5-phenyl-1,3-dihydro-2H-benzo[d]imidazol-2-one

IUPAC Name:3-benzyl-1-(cyclopropylmethyl)-5-phenyl-2,3-dihydro-1H-1,3-benzodiazol-2-one

CAS:1359757-43-9
Formule moléculaire:C24H22N2O
Pureté:95%
Numéro de catalogue:CM152698
Poids moléculaire:354.45

Unité d'emballage Stock disponible Prix($) Quantité
CM152698-1g in stock ǎǎǟƚ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1359757-43-9
Formule moléculaire:C24H22N2O
Point de fusion:-
Code SMILES:O=C1N(CC2CC2)C3=CC=C(C4=CC=CC=C4)C=C3N1CC5=CC=CC=C5
Densité:
Numéro de catalogue:CM152698
Poids moléculaire:354.45
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Benzimidazoles
Benzimidazole is a benzo derivative of imidazole. It is a kind of bicyclic aromatic organic compounds, which is formed by fusing a six-membered benzene ring and five-membered imidazole at positions 4 and 5 of imidazole ring. It is an important pharmacophore of many biologically active heterocyclic compounds with various pharmacological activities. Benzimidazoles and their derivatives have developed into dynamic heterocyclic systems due to their potency in a variety of biologically active compounds such as anticancer, bactericidal and antiviral drugs. Benzimidazoles are a class of therapeutic motifs with broad relevance in medicinal chemistry.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.